Insider Trading & Ownership - Fair Richard A.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fair Richard A.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-03-17
Purchase
2020-03-19
12:48 pm
BELLICUM PHARMACEUTICALS INCBLCMFair Richard A.
President and CEO
5,000$3.9997$19,99911,813
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-08-15
Option Award
2022-08-16
5:04 pm
N/A
2032-08-15
BELLICUM PHARMACEUTICALS INCBLCMFair Richard A.
President and CEO
400,000$1.44400,000
(Direct)
View
2021-08-16
Option Award(A)
2021-08-18
12:21 pm
2022-08-16
2031-08-16
BELLICUM PHARMACEUTICALS INCBLCMFair Richard A.
President and CEO
265,000$0265,000
(Direct)
View
2021-08-16
Option Award
2021-08-16
4:21 pm
N/A
2031-08-16
BELLICUM PHARMACEUTICALS INCBLCMFair Richard A.
President and CEO
265,000$0265,000
(Direct)
View
2021-06-10
Option Award
2021-06-11
8:48 pm
N/A
2031-06-10
Clovis Oncology Inc.CLVSFair Richard A.
Director
42,223$042,223
(Direct)
View
2020-12-15
Option Award
2020-12-16
1:54 pm
N/A
2030-12-14
BELLICUM PHARMACEUTICALS INCBLCMFair Richard A.
President and CEO
286,000$0286,000
(Direct)
View
2020-06-04
Option Award
2020-06-08
8:30 pm
N/A
2030-06-04
Clovis Oncology Inc.CLVSFair Richard A.
Director
40,138$040,138
(Direct)
View
2020-02-03
Option Award
2020-02-04
2:24 pm
N/A
2030-02-02
BELLICUM PHARMACEUTICALS INCBLCMFair Richard A.
President and CEO
1,257,000$01,257,000
(Direct)
View
(A) Indicate amendment filing.